摘要 |
A therapeutic and/or prophylactic agent for a hematopoietic tumor, which comprises a thiadiazoline derivative represented by the general formula (I), or a pharmaceutically acceptable salt thereof: [Formula 1] [wherein, n represents an integer of 1 to 3, R<SUP>1 </SUP>represents a hydrogen atom, R<SUP>2 </SUP>represents lower alkyl, or R<SUP>1 </SUP>and R<SUP>2 </SUP>are combined together to represent alkylene, R<SUP>3 </SUP>represents lower alkyl, R<SUP>4 </SUP>represents NHSO<SUB>2</SUB>R<SUP>6 </SUP>(wherein R<SUP>6 </SUP>represents hydroxy or the like) or the like, and R<SUP>5 </SUP>represents aryl or the like] and the like are provided.
|